Mar 19, 2021 09:21 AM IST
Germany, France, Italy and other European nations have announced plans to resume using AstraZeneca's COVID-19 vaccine.
- Mar 18, 2021 10:00 AM IST
The World Health Organization’s (WHO) has recommended a gap of 8-12 weeks between two doses of the AstraZeneca vaccine for better efficacy.
- Mar 17, 2021 07:47 AM IST
Coronavirus News Highlights: The cumulative number of COVID-19 vaccine doses administered in the country has crossed 3.48 crore, the Union health ministry said.
- Mar 16, 2021 08:09 PM IST
The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.
- Mar 16, 2021 01:02 PM IST
The World Health Organization has insisted the AstraZeneca shot is safe, and that there is no link between the vaccine and reported blood clots.
- Mar 14, 2021 06:01 PM IST
In January, Singh Deo had requested Union Health Minister Dr Harsh Vardhan to halt the supply of Covaxin, developed by Bharat Biotech, to the state until its phase-3 trials are completed and results are made available.
- Mar 13, 2021 09:52 PM IST
India has reported 234 adverse events following immunisation (AEFIs), including 71 deaths, for both the vaccines till Friday
- Mar 12, 2021 08:43 PM IST
Earlier, WHO said there was no reason to stop using AstraZeneca's COVID-19 vaccine after several European countries suspended the roll-out over blood clot fears.
- Mar 12, 2021 09:20 AM IST
Denmark, the first to announce it was suspending the jab, said that the move was precautionary.
- Mar 11, 2021 09:42 PM IST
So far, the government has allowed private health facilities to charge up to Rs 250 for one dose of the vaccine.
- Mar 10, 2021 07:29 AM IST
Coronavirus News Highlights : The cumulative number of COVID-19 vaccine doses administered in India has crossed 2.40 crore, according to the Union Health Ministry.
- Mar 09, 2021 07:35 AM IST
Coronavirus News Highlights: The cumulative number of COVID-19 vaccine doses administered in India has crossed 2.26 crore, according to the Union Health Ministry.
- Mar 04, 2021 02:22 PM IST
Government data shows dashboard.cowin.gov.in that only 10 percent of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81 percent effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said on Wednesday.
- Mar 04, 2021 12:24 PM IST
The Covishield vaccine was first administered to Kejriwal’s parents, Govind Ram Kejriwal and Gita Devi, and then to the chief minister.
- Mar 03, 2021 08:43 PM IST
Here is a comparison between the two COVID-19 vaccines – Covishield and Covaxin - approved in India.
- Mar 03, 2021 11:46 AM IST
COVID-19 vaccination drive was expanded on March 1 to include senior citizens and those aged 45-59 who have comorbidities.
- Mar 01, 2021 08:20 PM IST
In early January, India’s drug regulator had approved two vaccines — Bharat Biotech’s Covaxin and the Oxford/AstraZeneca-developed Covishield, which is being manufactured by Serum Institute of India (SII) — for emergency use in the country.
- Mar 01, 2021 10:28 AM IST
India has approved two vaccines—Covaxin developed by Hyderabad-based Bharat Biotech and Covishield from the Oxford-AstraZeneca stable being manufactured by the Serum Institute of India —for emergency use in the country.
- Feb 17, 2021 01:35 PM IST
Apart from Bharat Biotech’s Covaxin, Pune-based Serum Institute of India (SII) had collaborated with AstraZeneca and the University of Oxford and developed Covishield. This vaccine has been granted emergency approval in India. Let’s take a look at India’s vaccine diplomacy in various countries.
- Feb 16, 2021 08:52 AM IST
The second dose of COVID-19 vaccine is being given to those who received the first shot 28 days ago.
- Feb 15, 2021 08:35 PM IST
The inspection comes as countries around the world scramble to secure vaccine supplies amid supply disruptions and delivery cuts from leading drugmakers such as Pfizer Inc, Moderna and AstraZeneca.
- Feb 15, 2021 06:44 PM IST
Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.
- Feb 15, 2021 04:01 PM IST
Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine. Prime Minister Narendra Modi on February 10 had assured his Canadian counterpart Justin Trudeau that India would do its best to facilitate supplies of COVID vaccines sought by Canada.
- Feb 11, 2021 03:02 PM IST
Adar Poonawalla of Serum Institute of India speaks about his group’s NBFC interest, the rationale of the Magma Fincorp acquisition, RBI’s discussion paper for the segment and much more.
- Feb 07, 2021 11:07 AM IST
The highest number of people were vaccinated in Uttar Pradesh at 673,542 followed by Maharashtra at 463,044.